P-selectin-dependent monocyte recruitment through platelet interaction in intestinal microvessels of LPS-treated mice

Microcirculation

Volumn 15, Issue 5, 2008, Pages 441-450

  Higashiyama, Masaaki ^a   Hokari, Ryota ^a   Matsunaga, Hisayuki ^a   Takebayashi, Koichi ^a   Watanabe, Chikako ^a   Komoto, Shunsuke ^a   Okada, Yoshikiyo ^a   Kurihara, Chie ^a   Kawaguchi, Atsushi ^a   Nagao, Shigeaki ^a   Itoh, Kazuro ^a   Miura, Soichiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Monocytes; P selectin; Phosphodiesterase inhibitor

Indexed keywords

CILOSTAZOL; IBUDILAST; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; PADGEM PROTEIN; PADGEM PROTEIN ANTIBODY; PHOSPHODIESTERASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; ENTERITIS; INFLAMMATION; INTESTINE BLOOD FLOW; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; MALE; MICROVASCULATURE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; THROMBOCYTE ADHESION; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD PLATELETS; ENZYME INHIBITORS; INFLAMMATION; INTESTINAL DISEASES; INTESTINES; LIPOPOLYSACCHARIDES; MALE; MICE; MONOCYTES; P-SELECTIN; PHOSPHORIC DIESTER HYDROLASES; PLATELET ADHESIVENESS;

MURINAE; MUS;

EID: 46649096055     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1080/10739680701703551     Document Type: Article

References (44)

1. Sansonetti, P. (2002) Host-pathogen interactions: The seduction of molecular cross talk. Gut, 50, pp. III2-III8.
2. Burgio, VL, Fais, S., Boirivant, M., Perrone, A. and Pallone, F. (1995) Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. Gastroenterology, 109, pp. 1029-1038.
3. Rugtveit, J., Brandtzaeg, P., Halstensen, TS, Fausa, O. and Scott, H. (1994) Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut, 35, pp. 669-674.
4. Ishii, N., Tsuzuki, Y., Matsuzaki, K., Miyazaki, J., Okada, Y., Hokari, R., Kawaguchi, A., Nagao, S., Itoh, K. and Miura, S. (2004) Endotoxin stimulates monocyte-endothelial cell interactions in mouse intestinal Peyer's patches and villus mucosa. Clin Exp Immunol, 135, pp. 226-232.
5. Inoue, T., Tsuzuki, Y., Matsuzaki, K., Matsunaga, H., Miyazaki, J., Hokari, R., Okada, Y., Kawaguchi, A., Nagao, S., Itoh, K., Matsumoto, S. and Miura, S. (2005) Blockade of PSGL-1 attenuates CD14+ monocytic cell recruitment in intestinal mucosa and ameliorates ileitis in SAMP1/Yit mice. J Leukoc Biol, 77, pp. 287-295.
6. Moore, KL, Patel, KD, Bruehl, RE, Li, F., Johnson, DA, Lichenstein, HS, Cummings, RD, Bainton, DF and McEver, RP (1995) P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol, 128, pp. 661-671.
7. McEver, RP (2001) Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost, 86, pp. 746-756.
8. Salter, JW, Krieglstein, CF, Issekutz, AC and Granger, DN (2001) Platelets modulate ischemia/reperfusion-induced leukocyte recruitment in the mesenteric circulation. Am J Physiol Gastrointest Liver Physiol, 281, pp. G1432-G1439.
9. Collins, CE, Cahill, MR, Newland, AC and Rampton, DS (1994) Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology, 106, pp. 840-845.
10. Liu, Z., Colpaert, S., D'Haens, GR, Kasran, A., de Boer, M., Rutgeerts, P., Geboes, K. and Ceuppens, JL (1999) Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production. J Immunol, 163, pp. 4049-4057.
11. Suzuki, K., Sugimura, K., Hasegawa, K., Yoshida, K., Suzuki, A., Ishizuka, K., Ohtsuka, K., Honma, T., Narisawa, R. and Asakura, H. (2001) Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes. Scand J Gastroenterol, 36, pp. 1301-1306.
12. Danese, S., Motte, Cd Cde L. and Fiocchi, C. (2004) Platelets in inflammatory bowel disease: Clinical, pathogenic, and therapeutic implications. Am J Gastroenterol, 99, pp. 938-945.
13. Danese, S., Katz, JA, Saibeni, S., Papa, A., Gasbarrini, A., Vecchi, M. and Fiocchi, C. (2003) Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut, 52, pp. 1435-1441.
14. Danese, S., de la Motte, C., Sturm, A., Vogel, JD, West, GA, Strong, SA, Katz, JA and Fiocchi, C. (2003) Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology, 124, pp. 1249-1264.
15. Ohba, R., Otaka, M., Odashima, M., Jin, M., Komatsu, K., Konishi, N., Wada, I., Horikawa, Y., Matsuhashi, T., Oyake, J., Hatakeyama, N. and Watanabe, S. (2006) Effect of cilostazol, a selective type-III phosphodiesterase inhibitor, on water-immersion stress-induced gastric mucosal injury in rats. J Gastroenterol, 41, pp. 34-40.
16. Iba, T., Kidokoro, A., Fukunaga, M., Takuhiro, K., Ouchi, M. and Ito, Y. (2006) Comparison of the protective effects of type III phosphodiesterase (PDE3) inhibitor (cilostazol) and acetylsalicylic acid on intestinal microcirculation after ischemia reperfusion injury in mice. Shock, 26, pp. 522-526.
17. Schmidt, W., Tinelli, M., Secchi, A., Gebhard, MM, Martin, E. and Schmidt, H. (2000) Influence of amrinone on intestinal villus blood flow during endotoxemia. J Crit Care, 15, pp. 97-102.
18. Brindis, RG and Kloner, RA (2003) Sildenafil in patients with cardiovascular disease. Am J Cardiol, 92, pp. 26M-36M.
19. Boswell-Smith, V., Cazzola, M. and Page, CP (2006) Are phosphodiesterase 4 inhibitors just more theophylline?. J Allergy Clin Immunol, 117, pp. 1237-1243.
20. Dinter, H., Tse, J., Halks-Miller, M., Asarnow, D., Onuffer, J., Faulds, D., Mitrovic, B., Kirsch, G., Laurent, H., Esperling, P., Seidelmann, D., Ottow, E., Schneider, H., Tuohy, VK, Wachtel, H. and Perez, HD (2000) The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents. J Neuroimmunol, 108, pp. 136-146.
21. Lugnier, C. (2006) Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents. Pharmacol Ther, 109:3, pp. 366-398.
22. Kariyazono, H., Nakamura, K., Shinkawa, T., Yamaguchi, T., Sakata, R. and Yamada, K. (2001) Inhibition of platelet aggregation and the release of P-selectin from platelets by cilostazol. Thromb Res, 101, pp. 445-453.
23. Ito, H., Miyakoda, G. and Mori, T. (2004) Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation. Platelets, 15, pp. 293-301.
24. Sanz, MJ, Alvarez, A., Piqueras, L., Cerda, M., Issekutz, AC, Lobb, RR, Cortijo, J. and Morcillo, EJ (2002) Rolipram inhibits leukocyte-endothelial cell interactions in vivo through P- and E-selectin downregulation. Br J Pharmacol, 135, pp. 1872-1881.
25. Kamada, N., Hisamatsu, T., Okamoto, S., Sato, T., Matsuoka, K., Arai, K., Nakai, T., Hasegawa, A., Inoue, N., Watanabe, N., Akagawa, KS and Hibi, T. (2005) Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J Immunol, 15:17510, pp. 6900-6908.
26. Ishikawa, M., Cooper, D., Russell, J., Salter, JW, Zhang, JH, Nanda, A. and Granger, DN (2003) Molecular determinants of the prothrombogenic and inflammatory phenotype assumed by the postischemic cerebral microcirculation. Stroke, 34, pp. 1777-1782.
27. Tailor, A. and Granger, DN (2003) Hypercholesterolemia promotes P-selectin-dependent platelet-endothelial cell adhesion in postcapillary venules. Arterioscler Thromb Vasc Biol, 23, pp. 675-680.
28. Isenberg, WM, McEver, RP, Shuman, MA and Bainton, DF (1986) Topographic distribution of a granule membrane protein (GMP-140) that is expressed on the platelet surface after activation: An immunogold-surface replica study. Blood Cells, 12, pp. 191-204.
29. Johnston, GI, Kurosky, A. and McEver, RP (1989) Structural and biosynthetic studies of the granule membrane protein, GMP-140, from human platelets and endothelial cells. J Biol Chem, 25:264, pp. 1816-1823.
30. Lim, YC, Snapp, K., Kansas, GS, Camphausen, R., Ding, H. and Luscinskas, FW (1998) Important contributions of P-selectin glycoprotein ligand-1-mediated secondary capture to human monocyte adhesion to P-selectin, E-selectin, and TNF-alpha-activated endothelium under flow in vitro. J Immunol, 161, pp. 2501-2508.
31. Ong, E., Gao, XP, Predescu, D., Broman, M. and Malik, AB (2005) Role of phosphatidylinositol 3-kinase-gamma in mediating lung neutrophil sequestration and vascular injury induced by E. coli sepsis. Am J Physiol Lung Cell Mol Physiol, 289:6, p. L1094.
32. Sixt, M., Hallmann, R., Wendler, O., Scharffetter-Kochanek, K. and Sorokin, LM (2001) Cell adhesion and migration properties of beta 2-integrin negative polymorphonuclear granulocytes on defined extracellular matrix molecules. Relevance for leukocyte extravasation. J Biol Chem, 276:22, pp. 18878-18887.
33. Doucey, MA, Legler, DF, Faroudi, M., Boucheron, N., Baumgaertner, P., Naeher, D., Cebecauer, M., Hudrisier, D., Ruegg, C., Palmer, E., Valitutti, S., Bron, C. and Luescher, IF (2003) The beta1 and beta3 integrins promote T cell receptor-mediated cytotoxic T lymphocyte activation. J Biol Chem, 278:29, pp. 26983-26991.
34. Wegmann, F., Petri, B., Khandoga, AG, Moser, C., Khandoga, A., Volkery, S., Li, H., Nasdala, I., Brandau, O., Fassler, R., Butz, S., Krombach, F. and Vestweber, D. (2006) ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability. J Exp Med, 203:7, pp. 1671-1677.
35. Li, Z., Rumbaut, RE, Burns, AR and Smith, CW (2006) Platelet response to corneal abrasion is necessary for acute inflammation and efficient re-epithelialization. Invest Ophthalmol Vis Sci, 47:11, pp. 4794-4802.
36. Romo, GM, Dong, JF, Schade, AJ, Gardiner, EE, Kansas, GS, Li, CQ, McIntire, LV, Berndt, MC and Lopez, JA (1999) The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med, 190, pp. 803-814.
37. da Costa Martins, P, van den Berk, N, Ulfman, LH, Koenderman, L., Hordijk, PL and Zwaginga, JJ (2004) Platelet-monocyte complexes support monocyte adhesion to endothelium by enhancing secondary tethering and cluster formation. Arterioscler Thromb Vasc Biol, 24, pp. 193-199.
38. Horn, NA, Anastase, DM, Hecker, KE, Baumert, JH, Scheffer, GJ and Rossaint, R. (2006) Phosphodiesterase III inhibition affects platelet-monocyte aggregate formation depending on the axis of stimulation. J Cardiothorac Vasc Anesth, 20, pp. 162-166.
39. Waldkirch, E., Uckert, S., Yildirim, H., Sohn, M., Jonas, U., Stief, CG, Andersson, KE and Hedlund, P. (2005) Cyclic AMP-specific and cyclic GMP-specific phosphodiesterase isoenzymes in human cavernous arteries-immunohistochemical distribution and functional significance. World J Urol, 23:6, pp. 405-410.
40. Kishi, Y., Ohta, S., Kasuya, N., Sakita, S., Ashikaga, T. and Isobe, M. (2001) Ibudilast: A non-selective PDE inhibitor with multiple actions on blood cells and the vascular wall. Cardiovasc Drug Rev, 19, pp. 215-225.
41. Park, SY, Lee, JH, Kim, YK, Kim, CD, Rhim, Lee, WS and Hong, KW (2005) Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation. J Pharmacol Exp Ther, 312, pp. 1241-1248.
42. Hartmann, G., Bidlingmaier, C., Siegmund, B., Albrich, S., Schulze, J., Tschoep, K., Eigler, A., Lehr, HA and Endres, S. (2000) Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice. J Pharmacol Exp Ther, 292, pp. 22-30.
43. Diaz-Granados, N., Howe, K., Lu, J. and McKay, DM (2000) Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity. Am J Pathol, 156, pp. 2169-2177.
44. Vowinkel, T., Mori, M., Krieglstein, CF, Russell, J., Saijo, F., Bharwani, S., Turnage, RH, Davidson, WS, Tso, P., Granger, DN and Kalogeris, TJ (2004) Apolipoprotein A-IV inhibits experimental colitis. J Clin Invest, 114, pp. 260-269.